Adaptogenic effects

Adaptogenic effects refer to the physiological ability of certain pharmacological agents to enhance an organism's non-specific resistance to physical, chemical, or biological stressors while maintaining internal homeostasis (Panossian & Wikman, 2010). This term does not describe a discrete molecular target, such as a single receptor or enzyme, but rather a systemic outcome achieved through the complex modulation of multiple signaling pathways. The primary biological mediators associated with these effects include the Hypothalamic-Pituitary-Adrenal (HPA) axis, the sympathoadrenal system, and molecular regulators like Heat Shock Protein 70 (HSP70) and Nitric Oxide (Liao et al., 2018). Clinically, substances producing these effects—known as adaptogens—are utilized to mitigate the impact of chronic stress, fatigue, and age-related cognitive decline (Gerontikos, 2020). Because the term 'adaptogenic effects' represents a pharmacological property or clinical outcome rather than a specific biological entity, it is classified as an incorrect entry for a drug target. For drug development purposes, analysts should instead identify specific molecular mediators within the stress-response pathway, such as the Glucocorticoid Receptor or specific heat shock proteins, to define druggable targets.

Other names

Stress-protective effectsNon-specific resistanceAdaptogenesisHomeostatic regulationAdaptogenic activity

Adaptogens act by modulating the Hypothalamic-Pituitary-Adrenal (HPA) axis and the sympathoadrenal system, effectively 're-tuning' the stress response. They influence molecular chaperones such as Heat Shock Protein 70 (HSP70), regulate the levels of nitric oxide (NO), and balance cortisol production to prevent the exhaustion phase of the General Adaptation Syndrome (Panossian & Wikman, 2010).